Relationship between osteoprotegerin and mortality in decompensated heart failure with preserved ejection fraction

Abstract

Osteoprotegerin is independently associated with all-cause mortality in patients hospitalized for heart failure with preserved ejection fraction. However, adding this biomarker into a risk model does not improve its prediction value.